Oxidative bioactivation of Abacavir in subcellular fractions of human antigen presenting cells.
AffiliationMRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool , Liverpool L69 3GE, United Kingdom.
MetadataShow full item record
AbstractHuman exposure to abacavir, a primary alcohol antiretroviral, is associated with the development of immunological drug reactions in individuals carrying the HLA risk allele B*57:01. Interaction of abacavir with antigen presenting cells results in cell activation through an Hsp70-mediated Toll-like receptor pathway and the provision of T-cell antigenic determinants. Abacavir's electrophilic aldehyde metabolites are potential precursors of neoantigens. Herein, we have used mass spectrometry to study the oxidative metabolism of abacavir in EBV-transformed human B-cells. RNA and protein were isolated from the cells and subjected to transcriptomic and mass spectrometric analyses to identify the redox enzymes expressed. Low levels of isomeric abacavir carboxylic acids were detected in subcellular fractions of EBV-transformed human B-cells incubated with abacavir. Metabolite formation was time-dependent but was not reduced by an inhibitor of Class I alcohol dehydrogenases. Relatively high levels of mRNA were detected for several redox enzymes, including alcohol dehydrogenase 5 (Class III), aldehyde dehydrogenases (ALDH3A2, ALDH6A1, and ALDH9A1), CYP1B1, CYP2R1, CYP7B1, and hydroxysteroid dehydrogenase 10. Over 2600 proteins were identified by mass spectrometry. More than 1000 of these proteins exhibited catalytic activity, and 80 were oxido-reductases. This is the first proteomic inventory of enzymes in antigen presenting cells. However, neither of the hepatic alcohol dehydrogenases of Class I which metabolize abacavir in vitro was expressed at the protein level. Nevertheless the metabolic production of abacavir carboxylic acids by B-cell fractions implies abacavir-treated immune cells might be exposed to the drug's protein-reactive aldehyde metabolites in vivo.
CitationOxidative bioactivation of Abacavir in subcellular fractions of human antigen presenting cells. 2013: Chem Res Toxicol
JournalChemical Research in Toxicology
- The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes.
- Authors: Walsh JS, Reese MJ, Thurmond LM
- Issue date: 2002 Nov 10
- Reactive aldehyde metabolites from the anti-HIV drug abacavir: amino acid adducts as possible factors in abacavir toxicity.
- Authors: Charneira C, Godinho AL, Oliveira MC, Pereira SA, Monteiro EC, Marques MM, Antunes AM
- Issue date: 2011 Dec 19
- Bioactivation to an aldehyde metabolite--possible role in the onset of toxicity induced by the anti-HIV drug abacavir.
- Authors: Grilo NM, Charneira C, Pereira SA, Monteiro EC, Marques MM, Antunes AM
- Issue date: 2014 Jan 30
- T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms.
- Authors: Bell CC, Faulkner L, Martinsson K, Farrell J, Alfirevic A, Tugwood J, Pirmohamed M, Naisbitt DJ, Park BK
- Issue date: 2013 May 20
- Monitoring abacavir bioactivation in humans: screening for an aldehyde metabolite.
- Authors: Grilo NM, Antunes AM, Caixas U, Marinho AT, Charneira C, Conceição Oliveira M, Monteiro EC, Matilde Marques M, Pereira SA
- Issue date: 2013 May 10